| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/09/1999 | US5869520 Reducing intraocular pressure |
| 02/09/1999 | US5869518 Azacycloalkane derivatives, their preparation and their application in therapy |
| 02/09/1999 | US5869516 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 02/09/1999 | US5869515 1,3-dihydro-2H-imidazol-2-one compounds |
| 02/09/1999 | US5869514 Terpenoidic derivatives useful as antitumor agents |
| 02/09/1999 | US5869512 Azole compounds with antimycotic activity for human and veterinary use |
| 02/09/1999 | US5869511 Isoxazoline compounds as inhibitors of TNF release |
| 02/09/1999 | US5869509 Treat disorders responsive to openers of the large conductance calcium-activated potassium channels |
| 02/09/1999 | US5869507 Increased bioavailability; anti-tumor activity with selective inhibition of ras-transformed cell lines over wild-type cells |
| 02/09/1999 | US5869505 Nicotine metabolites and nicotine dependence |
| 02/09/1999 | US5869503 Nicotine metabolites and human body weight |
| 02/09/1999 | US5869502 Treating depression, obsessive compulsive disorder, stuttering, trichotillomania |
| 02/09/1999 | US5869501 Amidinonaphthyl derivative or salt thereof |
| 02/09/1999 | US5869499 Benzyloxyquinuclidines as substance P antagonists |
| 02/09/1999 | US5869498 Pain alleviating drug composition and method for alleviating pain |
| 02/09/1999 | US5869497 Method of treating or ameliorating the symptoms of common cold or allergic rhinitis |
| 02/09/1999 | US5869496 Treating asthma, emesis |
| 02/09/1999 | US5869495 Treatment and/or prophylaxis of hyperglycaemia |
| 02/09/1999 | US5869494 Administering as antitumor agents, immune system modulators and antidepressants |
| 02/09/1999 | US5869492 Condensed thiazole derivatives, having 5-HT receptor affinity |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869485 Treatment of diseases which respond to inhibition of the activity of the protein tyrosine kinase |
| 02/09/1999 | US5869482 Dipyridio 2,3-b:3',2'-! azepines and their use in the prevention or treatment of HIV infection |
| 02/09/1999 | US5869481 Treating epileptic disorders |
| 02/09/1999 | US5869480 Alleviating memory dysfunction characterized by cholinergic deficit |
| 02/09/1999 | US5869479 Administering histamine h1 receptor antagonists and histamine h3 receptor antagonists; nasal decongestant without the nervous system or cardiovascular side effects |
| 02/09/1999 | US5869478 Administering as antiischemic agents |
| 02/09/1999 | US5869477 β-methylcarbapenem derivatives, process for the preparation thereof and pharmaceutical composition comprising same |
| 02/09/1999 | US5869475 Certain 3-ketosteroids used to inhibit steroid 5α-reductase |
| 02/09/1999 | US5869474 Low dosage treatment for cocaine craving and withdrawal |
| 02/09/1999 | US5869473 Method for treating and preventing hyperparathyroidism |
| 02/09/1999 | US5869471 Methods for the treatment of arthritis using phosphonates and NSAIDS |
| 02/09/1999 | US5869470 Salicylic acid, retinoid |
| 02/09/1999 | US5869469 Modulating amyloid deposition |
| 02/09/1999 | US5869468 Treating glaucoma |
| 02/09/1999 | US5869467 Viricides |
| 02/09/1999 | US5869466 Vitamin B12 mediated oral delivery systems for GCSF |
| 02/09/1999 | US5869464 Having low toxicity, sustaining low concentration in blood for extended period |
| 02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |
| 02/09/1999 | US5869461 Reducing toxicity of L-nucleosides with D-nucleosides |
| 02/09/1999 | US5869460 Sulfated and phosphated saccharide derivatives, process for the preparation of the same and use thereof |
| 02/09/1999 | US5869454 Arginine keto-amide enzyme inhibitors |
| 02/09/1999 | US5869444 Osmotic agents for peritoneal dialysis |
| 02/09/1999 | US5869338 Contacting mammalian cells with an aminoalkylphosphorothioate or an associated aminoalkylphosphorothioate metabolite in an amount effective to modulate gene expression in said mammalian cells. |
| 02/09/1999 | US5869324 Chiral resolution by contacting mixture with enzyme and acylating agent, separating esterified calanolide a |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869246 Triplex Oligonucleotides targeted to p120 |
| 02/09/1999 | US5869102 Solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
| 02/09/1999 | US5869101 Process for the preparation of S(+)-ibuprofen-particles |
| 02/09/1999 | US5869100 Tablet comprising clonidine, cellulose ether, adjunct selected from corn starch, lactulose, dextrose |
| 02/09/1999 | US5869098 Includes at least one flowable, partially crystallized amorphous matrix comprising carbohydrate(s) and sugar alcohol(s) and a tableting aid with a bio-affecting agent |
| 02/09/1999 | US5869094 Solid form of administration of isosorbide 5-mononitrate |
| 02/09/1999 | US5869091 Aqueous vehicle, vesicle comprising nonionic surfactant, sterol and charged species suspended in aqueous vehicle and pharmaceutically active agent in both vesicle and aqueous vehicle |
| 02/09/1999 | US5869090 Transdermal delivery of dehydroepiandrosterone |
| 02/09/1999 | US5869088 Preparation containing fatty acid, fatty acid ester or alcohol as absorption enhancer |
| 02/09/1999 | US5869087 Patch having a preparation for external use attached thereto |
| 02/09/1999 | US5869086 Systems for the controlled release of pilocarpine |
| 02/09/1999 | US5869082 Buccal, non-polar spray for nitroglycerin |
| 02/09/1999 | US5869081 Progesterone vaginal ring for treatment of infertility |
| 02/09/1999 | US5869079 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 02/09/1999 | US5869068 Agonist substance of one or a number of receptors associated with a chlorine channel are useful for slackening and/or relaxing cutaneous tissue, and in particular for the purpose of treating wrinkles and fine lines of the skin. |
| 02/09/1999 | US5869067 Bi-aromatic compounds and pharmaceutical and cosmetic compositions |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | US5869036 Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| 02/09/1999 | US5869034 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution |
| 02/09/1999 | US5869031 Depigmenting dermatological and/or cosmetic composition |
| 02/09/1999 | US5869030 Sunscreen compositions comprising micronized, insoluble organic UV absorbers |
| 02/09/1999 | US5869024 Methods and compositions for using non-ionic contrast agents to reduce the risk of clot formation in diagnostic procedures |
| 02/09/1999 | CA2210023C Process for the preparation of paroxetine hydrochloride anhydrate form a. |
| 02/09/1999 | CA2163274C Intermediates for producing neuroleptic perhydro-1h-pyrido¬1,2-a| pyrazines |
| 02/09/1999 | CA2160137C Bicyclic ansamycins |
| 02/09/1999 | CA2151385C Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
| 02/09/1999 | CA2134413C Use of hydroxychloroquine for treatment of graft-versus-host disease |
| 02/09/1999 | CA2084519C Method for treating alcoholism with nalmefene |
| 02/09/1999 | CA1340382C Process for the preparation of 2-arylpropionic acids |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2244577A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/05/1999 | CA2238673A1 Novel aminopeptidase |
| 02/04/1999 | WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | WO1999005302A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | WO1999005299A1 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy |
| 02/04/1999 | WO1999005269A2 Transcriptional silencer protein nrf |
| 02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
| 02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 02/04/1999 | WO1999005156A1 Production of avermectin compounds |
| 02/04/1999 | WO1999005155A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 02/04/1999 | WO1999005150A1 Nucleotide analog composition and synthesis method |
| 02/04/1999 | WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 02/04/1999 | WO1999005146A1 Hyponatremia remedies |
| 02/04/1999 | WO1999005144A1 Novel compounds |
| 02/04/1999 | WO1999005143A1 Novel compounds |
| 02/04/1999 | WO1999005142A1 Novel compounds |
| 02/04/1999 | WO1999005140A1 Indole and 2,3-dihydroindole derivatives, their preparation and use |